Top Banner
Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South Africa Helen Cox , Jennifer Hughes, Sizulu Moyo, Johnny Daniels, Vivian Cox, Mark Nicol, Gilles van Cutsem and Virginia Azevedo
19

The global TB situation

Jan 15, 2016

Download

Documents

sharis

Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South Africa. Helen Cox , Jennifer Hughes, Sizulu Moyo , Johnny Daniels, Vivian Cox, Mark Nicol, Gilles van Cutsem and Virginia Azevedo. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript

PowerPoint Presentation

Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South AfricaHelen Cox, Jennifer Hughes, Sizulu Moyo, Johnny Daniels, Vivian Cox, Mark Nicol, Gilles van Cutsem and Virginia Azevedo

The global TB situationEstimated incidence, 2012Estimated number of deaths, 2012 940,000*(0.81.1 million)8.6 million(8.39.0 million)450,000(300,000600,000) All forms of TBMultidrug-resistant TBHIV-associated TB 1.1 million (1.01.2 million)320,000(300,000340,000)Source: WHO Global Tuberculosis Report 2013* Excluding deaths attributed to HIV/TB170,000(100,000240,000) Despite some improvements, TB still exerts an enormous global toll and in most high HIV and TB prevalence settings, TB is the leading cause of death among people living with HIVAccess to DR-TB treatmentWHO TB Report 2013~450,000 incident cases annually